Cite
HARVARD Citation
Puzanov, I. et al. (n.d.). Long-term outcome in BRAFV600E melanoma patients treated with vemurafenib: Patterns of disease progression and clinical management of limited progression. European journal of cancer. 51 (11), pp. 1435-1443. [Online].